Apogee Therapeutics News

Buy Rating for Apogee Therapeutics: Promising Prospects for Dupixent and APG808 in COPD Market

TipRanksMay 31 17:17 ET

Buy Rating on Apogee Therapeutics: Promising Drug Developments and Strong Financials

TipRanksMay 13 19:01 ET

Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Apogee Therapeutics, Inc. (APGE)

TipRanksMay 13 11:25 ET

Apogee Therapeutics Analyst Ratings

BenzingaMay 10 06:50 ET

Buy Rating Affirmed for Apogee Therapeutics as APG777 Shows Promise and Pipeline Progresses

TipRanksMar 26 06:30 ET

Analysts Are Bullish on These Healthcare Stocks: Apogee Therapeutics, Inc. (APGE), SAGE Therapeutics (SAGE)

TipRanksMar 26 06:16 ET

Buy Rating Endorsed for Apogee Therapeutics Amid Promising APG777 Phase 1 Results

TipRanksMar 6 06:30 ET

Apogee Therapeutics Analyst Ratings

BenzingaMar 5 12:54 ET

Stifel Nicolaus Sticks to Its Buy Rating for Apogee Therapeutics, Inc. (APGE)

TipRanksFeb 9 08:28 ET

Stifel Nicolaus Keeps Their Buy Rating on Apogee Therapeutics, Inc. (APGE)

TipRanksJan 15 21:05 ET

Guggenheim Maintains Buy on Apogee Therapeutics, Raises Price Target to $44

BenzingaJan 3 11:17 ET

Apogee Therapeutics Analyst Ratings

BenzingaJan 3 11:16 ET

BTIG Sticks to Its Buy Rating for Apogee Therapeutics, Inc. (APGE)

TipRanksJan 2 09:07 ET

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics, Inc. (APGE), Apollo Medical Holdings (AMEH) and Alcon (ALC)

TipRanksDec 31, 2023 05:30 ET

Apogee Therapeutics Analyst Ratings

BenzingaDec 20, 2023 08:42 ET

Wedbush Initiates Apogee Therapeutics at Outperform With $40 Price Target

MT NewswiresAug 8, 2023 07:05 ET

Apogee Therapeutics Analyst Ratings

BenzingaAug 8, 2023 05:16 ET

Analysts Offer Insights on Healthcare Companies: NovoCure (NVCR), Apogee Therapeutics, Inc. (APGE) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksAug 8, 2023 04:40 ET